TABLE 4.
Multivariate Analysis of Risk Factors for Death Among Neonates With HSV Infection
| Variable | Adjusted OR (95% CI)a | P |
|---|---|---|
| Delayed acyclovir therapy | 2.62 (1.34–5.09) | .005 |
| Age category | ||
| 0–7 d | Reference | |
| 8–14 d | 0.81 (0.42–1.56) | .525 |
| 15–21 d | 0.37 (0.15–0.95) | .039 |
| 22–28 d | 0.11 (0.02–0.77) | .027 |
a
The model also adjusted for propensity scores, year, race/ethnicity, vasoactive agent infusions, anticonvulsant therapy, blood product transfusions, endotracheal intubation, HSV testing of skin lesions, and HSV without complications.